Nov 18, 2025

Dr. Sev MacLaughlin, the CEO of DeLorean AI, has developed an AI platform to identify at-risk patients, including those with renal disease, cardiovascular disease, and mental health conditions. Serving smaller and mid-sized provider clinics, this approach supports the shift to value-based care by predicting adverse events, recommending preventive measures, and reducing hospitalizations and healthcare costs. By analyzing entire populations instead of samples, the platform avoids biases and overlooked subgroups inherent in traditional analytical methods.

Sev explains, "So I think there's an opportunity to not only give better care at the point of care, but also aid in the discovery or assist in the diagnosis of unknown diseases that people may have in the chronic format. That may be identifying chronic kidney disease patients five years earlier, so they can have a different treatment modality and directionality in their lives, or hypertension or cardiovascular disease." 

"We're very strong in renal. So both chronic kidney disease and end-stage renal failure, or patients on dialysis. And then the two comorbidities that most that are huge influences for that are cardiovascular disease, cardiovascular system, and diabetes. In addition to that, we do CD and pulmonary. And then we were asked by one of our largest clients, United Healthcare, to look at mental health. And I have to say another surprise to me is how important mental health is to the other disease states, so that mental health needs to be taken care of to ensure that those individuals are medically adherent, they're going to their appointments, they're taking their medications, they're taking their health seriously. And that is something that I learned was most important and needed to be treated in parallel with the primary care diagnosis."

#DeLoreanAI #PreventativeCare #RenalCare #MedAI #Diagnostics #PopulationHealth #RiskStratification

DeLoreanai.com

Listen to the podcast here